arrow_back Back to App

Combating Illicit Xylazine: New Rules for Veterinary Drug Control

This act aims to curb the illicit use of xylazine, a veterinary substance, by adding it to the list of controlled substances. Citizens with pets will still be able to legally use xylazine if prescribed by a veterinarian, but its illegal possession or distribution will face stricter penalties. The changes are intended to enhance public safety and combat the misuse of this substance.
Key points
Xylazine, a veterinary drug, will be added to the list of controlled substances, leading to stricter penalties for its illegal possession and distribution.
Legal use of xylazine by pet owners, based on a veterinary prescription, remains permitted.
Transition periods are introduced for manufacturers and veterinarians to comply with new labeling, storage, and registration requirements.
The Sentencing Commission is tasked with adjusting sentencing guidelines for xylazine-related offenses.
Government agencies will monitor and report to Congress on the prevalence of illicit xylazine use in the United States.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_545
Sponsor: Sen. Cortez Masto, Catherine [D-NV]
Process start date: 2025-02-12
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Combating Illicit Xylazine Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_545.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-02-12.

What are the main provisions?

Key points include:

  • Xylazine, a veterinary drug, will be added to the list of controlled substances, leading to stricter penalties for its illegal possession and distribution.
  • Legal use of xylazine by pet owners, based on a veterinary prescription, remains permitted.
  • Transition periods are introduced for manufacturers and veterinarians to comply with new labeling, storage, and registration requirements.
  • The Sentencing Commission is tasked with adjusting sentencing guidelines for xylazine-related offenses.
  • Government agencies will monitor and report to Congress on the prevalence of illicit xylazine use in the United States.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cortez Masto, Catherine [D-NV].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Courts and Law Health